- call +1-201-465-4211
- email sales@mrinsights.biz
The development and manufacturing of sterile injectables is highly complex and capital intensive.
The operative cost for injectable is high as almost all injectables in present pharma market are toxic and infectious in natural, consequently, requiring a higher level of quality and significant care needs to be taken in order to ensure safe manufacture, packaging, storage, and distribution.
Scope of the Report:
This report focuses on the Sterile Injectables in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Increasing use of biologics in healthcare industry, with the gaining prominence, the emergence of antibody-drug conjugates (ADCs) and monoclonal antibodies (MA) into the drug development and clinical pipeline, has spurred growth of the sterile injectable market worldwide.
The worldwide market for Sterile Injectables is expected to grow at a CAGR of roughly 7.1% over the next five years, will reach 520 million US$ in 2023, from 340 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Baxter International Inc
AstraZeneca plc
Merck & Co., Inc
Novartis AG
Johnson & Johnson Services, Inc
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Large Molecules
Small Molecules
Market Segment by Applications, can be divided into
Cancer
Diabetes
Cardiovascular Diseases
Central Nervous Systems
Infectious Disorders
Musculoskeletal
There are 15 Chapters to deeply display the global Sterile Injectables market.
Chapter 1, to describe Sterile Injectables Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Sterile Injectables, with sales, revenue, and price of Sterile Injectables, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Sterile Injectables, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Sterile Injectables market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Sterile Injectables sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Sterile Injectables Introduction
1.2 Market Analysis by Type
1.2.1 Large Molecules
1.2.2 Small Molecules
1.3 Market Analysis by Applications
1.3.1 Cancer
1.3.2 Diabetes
1.3.3 Cardiovascular Diseases
1.3.4 Central Nervous Systems
1.3.5 Infectious Disorders
1.3.6 Musculoskeletal
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Baxter International Inc
2.1.1 Business Overview
2.1.2 Sterile Injectables Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Baxter International Inc Sterile Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 AstraZeneca plc
2.2.1 Business Overview
2.2.2 Sterile Injectables Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca plc Sterile Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck & Co., Inc
2.3.1 Business Overview
2.3.2 Sterile Injectables Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck & Co., Inc Sterile Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis AG
2.4.1 Business Overview
2.4.2 Sterile Injectables Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis AG Sterile Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson Services, Inc
2.5.1 Business Overview
2.5.2 Sterile Injectables Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson Services, Inc Sterile Injectables Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Sterile Injectables Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Sterile Injectables Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Sterile Injectables Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Sterile Injectables Manufacturer Market Share in 2017
3.3.2 Top 6 Sterile Injectables Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Sterile Injectables Market Analysis by Regions
4.1 Global Sterile Injectables Sales, Revenue and Market Share by Regions
4.1.1 Global Sterile Injectables Sales and Market Share by Regions (2013-2018)
4.1.2 Global Sterile Injectables Revenue and Market Share by Regions (2013-2018)
4.2 North America Sterile Injectables Sales and Growth Rate (2013-2018)
4.3 Europe Sterile Injectables Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Sterile Injectables Sales and Growth Rate (2013-2018)
4.5 South America Sterile Injectables Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Sterile Injectables Sales and Growth Rate (2013-2018)
5 North America Sterile Injectables by Countries
5.1 North America Sterile Injectables Sales, Revenue and Market Share by Countries
5.1.1 North America Sterile Injectables Sales and Market Share by Countries (2013-2018)
5.1.2 North America Sterile Injectables Revenue and Market Share by Countries (2013-2018)
5.2 United States Sterile Injectables Sales and Growth Rate (2013-2018)
5.3 Canada Sterile Injectables Sales and Growth Rate (2013-2018)
5.4 Mexico Sterile Injectables Sales and Growth Rate (2013-2018)
6 Europe Sterile Injectables by Countries
6.1 Europe Sterile Injectables Sales, Revenue and Market Share by Countries
6.1.1 Europe Sterile Injectables Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Sterile Injectables Revenue and Market Share by Countries (2013-2018)
6.2 Germany Sterile Injectables Sales and Growth Rate (2013-2018)
6.3 UK Sterile Injectables Sales and Growth Rate (2013-2018)
6.4 France Sterile Injectables Sales and Growth Rate (2013-2018)
6.5 Russia Sterile Injectables Sales and Growth Rate (2013-2018)
6.6 Italy Sterile Injectables Sales and Growth Rate (2013-2018)
7 Asia-Pacific Sterile Injectables by Countries
7.1 Asia-Pacific Sterile Injectables Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Sterile Injectables Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Sterile Injectables Revenue and Market Share by Countries (2013-2018)
7.2 China Sterile Injectables Sales and Growth Rate (2013-2018)
7.3 Japan Sterile Injectables Sales and Growth Rate (2013-2018)
7.4 Korea Sterile Injectables Sales and Growth Rate (2013-2018)
7.5 India Sterile Injectables Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Sterile Injectables Sales and Growth Rate (2013-2018)
8 South America Sterile Injectables by Countries
8.1 South America Sterile Injectables Sales, Revenue and Market Share by Countries
8.1.1 South America Sterile Injectables Sales and Market Share by Countries (2013-2018)
8.1.2 South America Sterile Injectables Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Sterile Injectables Sales and Growth Rate (2013-2018)
8.3 Argentina Sterile Injectables Sales and Growth Rate (2013-2018)
8.4 Colombia Sterile Injectables Sales and Growth Rate (2013-2018)
9 Middle East and Africa Sterile Injectables by Countries
9.1 Middle East and Africa Sterile Injectables Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Sterile Injectables Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Sterile Injectables Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Sterile Injectables Sales and Growth Rate (2013-2018)
9.3 UAE Sterile Injectables Sales and Growth Rate (2013-2018)
9.4 Egypt Sterile Injectables Sales and Growth Rate (2013-2018)
9.5 Nigeria Sterile Injectables Sales and Growth Rate (2013-2018)
9.6 South Africa Sterile Injectables Sales and Growth Rate (2013-2018)
10 Global Sterile Injectables Market Segment by Type
10.1 Global Sterile Injectables Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Sterile Injectables Sales and Market Share by Type (2013-2018)
10.1.2 Global Sterile Injectables Revenue and Market Share by Type (2013-2018)
10.2 Large Molecules Sales Growth and Price
10.2.1 Global Large Molecules Sales Growth (2013-2018)
10.2.2 Global Large Molecules Price (2013-2018)
10.3 Small Molecules Sales Growth and Price
10.3.1 Global Small Molecules Sales Growth (2013-2018)
10.3.2 Global Small Molecules Price (2013-2018)
11 Global Sterile Injectables Market Segment by Application
11.1 Global Sterile Injectables Sales Market Share by Application (2013-2018)
11.2 Cancer Sales Growth (2013-2018)
11.3 Diabetes Sales Growth (2013-2018)
11.4 Cardiovascular Diseases Sales Growth (2013-2018)
11.5 Central Nervous Systems Sales Growth (2013-2018)
11.6 Infectious Disorders Sales Growth (2013-2018)
11.7 Musculoskeletal Sales Growth (2013-2018)
12 Sterile Injectables Market Forecast (2018-2023)
12.1 Global Sterile Injectables Sales, Revenue and Growth Rate (2018-2023)
12.2 Sterile Injectables Market Forecast by Regions (2018-2023)
12.2.1 North America Sterile Injectables Market Forecast (2018-2023)
12.2.2 Europe Sterile Injectables Market Forecast (2018-2023)
12.2.3 Asia-Pacific Sterile Injectables Market Forecast (2018-2023)
12.2.4 South America Sterile Injectables Market Forecast (2018-2023)
12.2.5 Middle East and Africa Sterile Injectables Market Forecast (2018-2023)
12.3 Sterile Injectables Market Forecast by Type (2018-2023)
12.3.1 Global Sterile Injectables Sales Forecast by Type (2018-2023)
12.3.2 Global Sterile Injectables Market Share Forecast by Type (2018-2023)
12.4 Sterile Injectables Market Forecast by Application (2018-2023)
12.4.1 Global Sterile Injectables Sales Forecast by Application (2018-2023)
12.4.2 Global Sterile Injectables Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Sterile Injectables Picture
Table Product Specifications of Sterile Injectables
Figure Global Sales Market Share of Sterile Injectables by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
